![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 239/70 | |
A61K 31/496 |
(11) | Number of the document | 2694485 |
(13) | Kind of document | T |
(96) | European patent application number | 12765234.5 |
Date of filing the European patent application | 2012-03-30 | |
(97) | Date of publication of the European application | 2014-02-12 |
(45) | Date of publication and mention of the grant of the patent | 2017-11-15 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2012/031665 |
Date | 2012-03-30 |
(87) | Number | WO 2012/135750 |
Date | 2012-10-04 |
(30) | Number | Date | Country code |
201161470803 P | 2011-04-01 | US | |
201161470624 P | 2011-04-01 | US |
(72) |
HOEFLICH, Klaus, US
MERCHANT, Mark, US
|
(73) |
Genentech, Inc.,
One DNA Way, South San Francisco, CA 94080-4990,
US
|
(54) | COMBINATION OF AKT INHIBITOR COMPOUND AND VEMURAFENIB FOR USE IN THERAPEUTIC TREATMENTS |
COMBINATION OF AKT INHIBITOR COMPOUND AND VEMURAFENIB FOR USE IN THERAPEUTIC TREATMENTS |